







| Catalog No. | HT073016 |
|---|---|
| Description |
Faricimab (HT073016) is a research-grade recombinant antibody targeting Vascular endothelial growth factor A. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| Species reactivity | Human |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Host species | Human |
| Isotype | IgG1-kappa-lambda |
| Expression system | Mammalian cells |
| Clonality | Monoclonal |
| Target | Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A, ANG-2, ANGPT2, Angiopoietin-2 |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Accession | P15692 & O15123 |
| Form | Liquid |
| Storage buffer | 20 mM His, 140mM NaCl, pH6.0 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternate Names | Bispecific, RG7716, RO6867461, 1607793-29-2 |
| Background | Zifibancimig is an anti-VEGFA/ANGPT2 IgG1κ monoclonal antibody. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |

SDS-PAGE for Research Grade Faricimab

Detects Human ANGPT2 in indirect ELISAs.

Detects VEGFA in indirect ELISAs.

Detects Recombinant Human VEGFA/VEGF165 Protein, C-His (Cat No.: HB941011) in indirect ELISA.




Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com








+86-27-87433958
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский